LncRNA CHROMR was overexpressed in rituximab-resistant DLBCL cell lines with the logFC (resistant-sensitive) of 3.43 by bioinformatics analysis in the GSE159852 dataset (7). This evidence concerns the gene CHROMR and diffuse large B-cell lymphoma.